Trademark Overview
On Saturday, July 11, 2026, a trademark application was filed for NEUROVANA with the United States Patent and Trademark Office. The USPTO has given the NEUROVANA trademark a serial number of 99934770. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, July 11, 2026. This trademark is owned by Brain Initiative, Inc.. The NEUROVANA trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Wearable non-invasive brain-machine interface devices; transcranial neural signal acquisition and processing apparatus; wearable electronic sensors for detecting, amplifying, and transmitting neural signals from outside the skull; neural signal noise reduction apparatus; brain-computer interface hardware for translating neural activity into digital commands; wearable electronic devices for brain-to-brain and brain-to-machine communication; multi-sensory neural interface peripherals for transmitting visual, auditory, tactile, olfactory, gustatory, proprioceptive, vestibular, and interoceptive information; downloadable software for neural signalprocessing, decoding, and encoding; downloadable software forreal-time brain-to-machine and brain-to-brain communication; downloadable mobile applications for controlling and monitoring brain-machine interface devices; electronic sensors and electrodes for non-invasive neural recording.
research and development services in the field of non-invasive brain-machine interfaces, transcranial signal enhancement, and neural noisereduction; design and development of neural interface hardware and software; providing online non-downloadable software for neural signal analysis and sensory mapping; software as a service (SaaS) providing a platform for real-time brain-to-machine and brain-to-brain communication; scientific and technological consulting services in the field of brain-computer interface technology; providing application programming interfaces (APIs) for integrating brain-machine interface functionality into third-party applications; Software as a service (SaaS) featuring software for non-invasive brain-machine interface signal processing, neural decoding, and neural encoding
